臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"whang peng j"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 111-160 / 215 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
國家衛生研究院	2007-03	Effect of age on pulmonary metastases and immunotherapy in young and middle-aged mice	Chen, YM;Wang, PS;Liu, JM;Hsieh, YL;Tsai, CM;Perng, RP;Whang-Peng, J
國家衛生研究院	2007-02-01	Monitoring and quantitative assessment of tumor burden using in vivo bioluminescence imaging	Chen, CC; Hwang, JJ; Ting, G; Tseng, YL; Wang, SJ; Whang-Peng, J
國家衛生研究院	2007-02	Renal cell carcinoma with t(X;17)(p11.2;q25) in a 6-year-old Taiwanese boy	Chen, CK; Hsueh, C; Lai, JY; Hung, IJ; Whang-Peng, J; Wang, WP; Lai, HY; Chen, JR
國家衛生研究院	2006-12-20	Therapeutic efficacy evaluation of 111in-VNB-liposome on human colorectal adenocarcinoma HT-29/luc mouse xenografts	Lee, WC; Hwang, JJ; Tseng, YL; Wang, HE; Chang, YF; Lu, YC; Ting, G; Whang-Peng, J; Wang, SJ
國家衛生研究院	2006-12-20	Internal radiotherapy and dosimetric study for In-111/Lu-177-pegylated liposomes conjugates in tumor-bearing mice	Wang, HE; Yu, HM; Lu, YC; Heish, NN; Tseng, YL; Huang, KL; Chuang, KT; Chen, CH; Hwang, JJ; Lin, WJ; Wang, SJ; Ting, G; Whang-Peng, J; Deng, WP
國家衛生研究院	2006-11	Phase I and pharmacokinetic study of oral thalidomide in patients with advanced hepatocellular carcinoma	Shiah, HS; Chao, Y; Chen, LT; Yao, TJ; Huang, JD; Chang, JY; Chen, PJ; Chuang, TR; Chin, YH; Whang-Peng, J; Liu, TW
國家衛生研究院	2006-10-01	Identification of alpha-enolase as an autoantigen in lung cancer: Its overexpression is associated with clinical outcomes	Chang, GC; Liu, KJ; Hsieh, CL; Hu, TS; Charoenfuprasert, S; Liu, HK; Luh, KT; Hsu, LH; Wu, CW; Ting, CC; Chen, CY; Chen, KC; Yang, TY; Chou, TY; Wang, WH; Whang-Peng, J; Shih, NY
國家衛生研究院	2006-07	Salvage therapy for Chinese non-small cell lung cancer patients who failed previous chemotherapy	Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國家衛生研究院	2006-06	A phase II trial of gemcitabine plus UFUR combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy	Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院	2006-05	Phase I study of biweekly gemcitabine followed by oxaliplatin and simplified 48-h infusion of fluorouracil/leucovorin for advanced pancreatic cancer	Ch'ang, HJ; Wang, CC; Cheng, AL; Hsu, C; Lu, YS; Chang, MC; Lin, JT; Wang, HP; Shiah, HS; Liu, TW; Chang, JY; Whang-Peng, J; Chen, LT
國家衛生研究院	2006-04	Nodal dissection for patients with gastric cancer: a randomised controlled trial	Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Chen, JH; Li, AFY; Lui, WY; Whang-Peng, J
國家衛生研究院	2006-04	A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy	Chen, YM; Shih, JF; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院	2006-04	Erlotinib completely reverses topotecan-resistance in multidrug resistant cancer cells overexpressing breast cancer resistant protein 1	Yang, CH;Yang, CS;Huang, CJ;Cheng, AL;Whang-Peng, J;Yang, PC
國家衛生研究院	2006-04	Topoisomerase 2 alpha plays a pivotal role in the tumor biology of advanced thymic neoplasia	Liu, JM;Hwang, BS;Wang, LS;Huang, MH;Yen, SH;Li, A;Tiu, CM;Whang-Peng, J
國家衛生研究院	2006-03	Phase I-II trial of weekly gemcitabine plus high-dose 5-fluorouracil and leucovorin in advanced pancreatic cancer	Shiah, HS; Cheng, AL; Hsu, C; Hsu, CH; Liu, TW; Chang, JY; Jan, CM; Chao, Y; Yu, WL; Chuang, TR; Whang-Peng, J; Chen, LT
國家衛生研究院	2006-02	A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly	Chen, YM; Perng, RP; Tsai, CM; Whang-Peng, J
國家衛生研究院	2006-01	Complications following D3 gastrectomy: Post hoc analysis of a randomized trial	Wu, CW; Chang, IS; Lo, SS; Hsieh, MC; Chen, JH; Lui, WY; Whang-Peng, J
國家衛生研究院	2005-12	Pulmonary embolism after transcatheter arterial chemoembolization	Shiah, HS; Liu, TW; Chen, LT; Chang, JY; Liu, JM; Chuang, TR; Lee, WS; Whang-Peng, J
國家衛生研究院	2005-09-21	Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma	Chen, LT; Lin, JT; Tai, JJ; Chen, GH; Yeh, HZ; Yang, SS; Wang, HP; Kuo, SH; Sheu, BS; Jan, CM; Wang, WM; Wang, TE; Wu, CW; Chen, CL; Su, IJ; Whang-Peng, J; Cheng, AL
國家衛生研究院	2005-09-14	Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients	Su, WP;Wen, CC;Hsiung, CA;Su, IJ;Cheng, AL;Chang, MC;Tsao, CJ;Kao, WY;Uen, WC;Hsu, CH;Lu, YS;Tien, HF;Chao, TY;Chen, LT;Whang-Peng, J;Chen, PJ
國家衛生研究院	2005-09	Long-term complete remission of metastatic gastric cancer after weekly docetaxel, 24 h infusion of high-dose 5-FU/leucovorin and cisplatin	Chan, CH; Liu, TW; Chen, LT; Chang, JY; Whang-Peng, J
國家衛生研究院	2005-08-01	Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein	Yang, CH; Huang, CJ; Yang, CS; Chu, YC; Cheng, AL; Whang-Peng, J; Yang, PC
國家衛生研究院	2005-08-01	alpha-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma	Chen, LT; Liu, TW; Chao, Y; Shiah, HS; Chang, JY; Juang, SH; Chen, SC; Chuang, TR; Chin, YH; Whang-Peng, J
中國醫藥大學	2005-08	α-fetoprotein response predicts survival benefits of thalidomide in advanced hepatocellular carcinoma	(Chen. L.-T.); (Liu, T.-W.); (Chao, Y); (Shiah, H.-S); (Chang, J.-Y.,); 莊聲宏(Shin-Hun Juang); (Chen, S.-C.); (Chuang, T.-R); (Chin, Y.-H.); (Whang-Peng, J.)
國家衛生研究院	2005-07	erb-b2 amplification by fluorescence in situ hybridization in breast cancer specimens read as 2+in immunohistochemical analysis	Lan, C; Liu, JM; Liu, TW; Hsu, DH; Liang, SC; Chen, JR; Whang-Peng, J
國家衛生研究院	2005-07	Chemotherapy for non-small cell lung cancer in elderly patients	Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國立臺灣大學	2005-07	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment.	Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Kun-Huei, Yeh; Yu, YC; Whang-Peng, J; Yang, PC.
國家衛生研究院	2005-06	A phase II trial of UFUR plus gemcitabine in non-small cell lung cancer patients failing previous platinum-based chemotherapy	Chen, YM;Perng, RP;Tsai, CM;Whang-Peng, J
國家衛生研究院	2005-05-20	Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma	Chan, ATC; Hsu, MM; Goh, BC; Hui, EP; Liu, TW; Millward, MJ; Hong, RL; Whang-Peng, J; Ma, BBY; To, KF; Mueser, M; Amellal, N; Lin, X; Chang, AY
國家衛生研究院	2005-03	A randomized phase II study of vinorelbine plus gemcitabine with/without cisplatin against inoperable non-small-cell lung cancer previously untreated	Chen, YM; Perng, RP; Shih, JF; Tsai, CM; Whang-Peng, J
國家衛生研究院	2005-03	Stage migration influences on stage-specific survival comparison between D1 and D3 gastric cancer surgeries	Wu, CW;Hsiung, CA;Lo, SS;Hsieh, MC;Chen, JH;Li, AF;Lui, WY;Whang-Peng, J
國家衛生研究院	2005-02-15	A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma	Chang, GC; Lan, HC; Juang, SH; Wu, YC; Lee, HC; Hung, YM; Yang, HY; Whang-Peng, J; Liu, KJ
中國醫藥大學	2005-02	A pilot clinical trial of vaccination with dendritic cells pulsed with autologous tumor cells derived from malignant pleural effusion in patients with late-stage lung carcinoma.	(Chang, G.-C.); (Lan, H.-C); 莊聲宏(Shin-Hun Juang); (Wu, Y.-C.); (Lee, H.-C.); (Hung, Y.-M); (Yang, H.-Y.); (Whang-Peng, J); (Liu, K.-J)
國家衛生研究院	2005	Survival outcome of inoperable non-small cell lung cancer patients receiving conventional dose epirubicin and paclitaxel as first-line treatment	Yang, CH; Chen, MC; Cheng, AL; Hsu, CH; Yeh, KH; Yu, YC; Whang-Peng, J; Yang, PC
高雄醫學大學	2005	Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.	陳立宗;林肇堂;許博翔;詹昌明;王文明;王蒼恩;鄭安理 ; Chen LT;Lin JT;Tai JJ;Chen GH;Yeh HZ;Yang SS;Wang HP;Kuo SH;Sheu BS;Jan CM;Wang WM;Wang TE;Wu CW;Chen CL;Su IJ;Whang-Peng J;Cheng AL
高雄醫學大學	2005	Pulmonary embolism after transcatheter arterial chemoembolization	劉滄梧;陳立宗;彭汪嘉康 ; Shiah HS;Liu TW;Chen LT;Chang JY;Liu JM;Chuang TR;Lee WS;Whang-Peng J
臺大學術典藏	2005	Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients	Lu Y.-S.; Tien H.-F.; Chao T.-Y.; Chen L.-T.; Whang-Peng J.; Chen P.-J.; CHIH-HUNG HSU; Uen W.-C.; Su W.-P.;Wen C.-C.;Hsiung C.A.;Su I.-J.;Cheng A.-L.;Chang M.-C.;Tsao C.-J.;Kao W.-Y.;Uen W.-C.;Chih-Hung Hsu;Lu Y.-S.;Tien H.-F.;Chao T.-Y.;Chen L.-T.;Whang-Peng J.;Chen P.-J.; Su W.-P.; Wen C.-C.; Hsiung C.A.; Su I.-J.; Cheng A.-L.; Chang M.-C.; Tsao C.-J.; Kao W.-Y.
臺大學術典藏	2005	Long-term hepatic consequences of chemotherapy-related HBV reactivation in lymphoma patients	Chen P.-J.; Whang-Peng J.; Chen L.-T.; Chao T.-Y.; HWEI-FANG TIEN; Lu Y.-S.; Hsu C.-H.; Kao W.-Y.; Uen W.-C.; Tsao C.-J.; Chang M.-C.; Cheng A.-L.; Su I.-J.; Su W.-P.; Wen C.-C.; Hsiung C.A.
國家衛生研究院	2004-12	In vitro hepatic differentiation of human mesenchymal stem cells	Lee, KD; Kuo, TKC; Whang-Peng, J; Chung, YF; Lin, CT; Chou, SH; Chen, JR; Chen, YP; Lee, OKS
國家衛生研究院	2004-12	Prognostic implications of the expression of erbB2, topoisomerase II alpha and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy	Liu, JM; Chen, LT; Li, AFY; Wu, CW; Lan, C; Chung, TR; Shiah, HS; Lee, KD; Liu, TW; Whang-Peng, J
國家衛生研究院	2004-09	Current status of clinical studies for colorectal cancer in Taiwan	Chen, L;Whang-Peng, J
國家衛生研究院	2004-09	Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies	Li, C;Huang, T;Chao, Y;Chang, F;Whang-Peng, J;Lee, S
國家衛生研究院	2004-07	Impact of severe acute respiratory syndrome on the status of lung cancer chemotherapy patients and a correlation of the signs and symptoms	Chen, YM; Perng, RP; Chu, H; Tsai, CM; Whang-Peng, J
國家衛生研究院	2004-07	Preliminary report of a randomized trial of different docetaxel schedules in non-small cell lung cancer patients failing previous chemotherapy	Chen, YM;Shih, JF;Tsai, CM;Perng, RP;Whang-Peng, J
國家衛生研究院	2004-04-15	Generation of carcinoembryonic antigen (CEA)-specific T-cell responses in HLA-A0201 and HLA-A2402 late-stage colorectal cancer patients after vaccination with dendritic cells loaded with CEA peptides	Liu, KJ; Wang, CC; Chen, LT; Cheng, AL; Lin, DT; Wu, YC; Yu, WL; Hung, YM; Yang, HY; Juang, SH; Whang-Peng, J
中國醫藥大學	2004-04	Generation of CEA-specific T-cell response in HLA-A0201 and HLA-A2402 late-stage colorectal cancer patients following vaccination with dendritic cells loaded with CEA peptides.	(Liu, K.-J.*); (Wang, C.-C.); (Chen, L.-T.); (Cheng, A.-L.); (Lin, D.-T.); (Wu, Y.-C.); (Yu, W.-L); (Hung, Y.-M.); 莊聲宏(Shin-Hun Juang); (Whang-Peng, J)
國家衛生研究院	2004-03	Randomized clinical trial of morbidity after D1 and D3 surgery for gastric cancer	Wu, CW; Hsiung, CA; Lo, SS; Hsieh, MC; Shia, LT; Whang-Peng, J
國家衛生研究院	2004-02-26	A randomised phase II study of weekly paclitaxel or vinorelbine in combination with cisplatin against inoperable non-small-cell lung cancer previously untreated	Chen, YM; Perng, RP; Shih, JF; Lee, YC; Lee, CS; Tsai, CM; Whang-Peng, J
國家衛生研究院	2004-02	Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8(+) T cells	Liu, KJ; Lu, LF; Cheng, HT; Hung, YM; Shiou, SR; Whang-Peng, J; Juang, SH
中國醫藥大學	2004-02	Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells	(Liu K.-J); (Lu L.-F.); (Cheng H.-T.); (Hung Y.-M.); (Shiou S.-R.); (Whang-Peng J); 莊聲宏(Shin-Hun Juang)

顯示項目 111-160 / 215 (共5頁)
<< < 1 2 3 4 5 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51802907 線上人數 : 1049 教育部委託研究計畫計畫執行:國立臺灣大學圖書館